Drug Insight: the use of melatonergic agonists for the treatment of insomnia—focus on ramelteon

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Nature Clinical Practice Neurology

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ncpneuro0467PMID 17410109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod.

  2019cited by this paper
• Acute and chronic effects of ramelteon in rhesus monkeys (Macaca mulatta): dependence liability studies.

  2006cited by this paper
• Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.

  2006cited by this paper
• Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

  2006cited by this paper
• Melatonin: Nature's most versatile biological signal?

  2006cited by this paper
• Neurobiology of the Sleep-Wake Cycle: Sleep Architecture, Circadian Regulation, and Regulatory Feedback

  2006cited by this paper
• Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia.

  2006cited by this paper
• Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?

  2006cited by this paper
• The Circadian Body Temperature Rhythm in the Elderly: Effect of Single Daily Melatonin Dosing

  2006cited by this paper
• An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.

  2006cited by this paper
• Ramelteon: a novel treatment for the treatment of insomnia

  2006cited by this paper
• Agomelatine targets a range of major depressive disorder symptoms.

  2006cited by this paper
• Effect of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, on motor performance in mice.

  2006cited by this paper
• Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

  2006cited by this paper
• Disposition Kinetics and Tolerance of Escalating Single Doses of Ramelteon, a High‐Affinity MT1 and MT2 Melatonin Receptor Agonist Indicated for Treatment of Insomnia

  2006cited by this paper
• Horomone Therapy for Vasomotor Symptoms

  2006cited by this paper
• Melatonin as a hypnotic: con.

  2005cited by this paper
• Cutaneous warming promotes sleep onset.

  2005cited by this paper
• The basic physiology and pathophysiology of melatonin.

  2005cited by this paper
• Effects of exogenous melatonin on sleep: a meta-analysis.

  2005cited by this paper
• TAK-375 Takeda.

  2005cited by this paper
• Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.

  2005cited by this paper
• Functional MT1 and MT2 melatonin receptors in mammals

  2005cited by this paper
• Sleep laboratory investigations on hypnotic properties of melatonin

  2005cited by this paper
• Melatonin as a chronobiotic.

  2005cited by this paper
• Ramelteon (TAK-375) Accelerates Reentrainment of Circadian Rhythm after a Phase Advance of the Light-Dark Cycle in Rats

  2005cited by this paper
• Recent Advances in Melatonin Receptor Ligands

  2005cited by this paper
• Fresh from the pipeline: Ramelteon.

  2005cited by this paper
• Thermoregulation as a sleep signaling system.

  2004cited by this paper
• Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists.

  2004cited by this paper
• The sleep-promoting action of ramelteon (TAK-375) in freely moving cats.

  2004cited by this paper
• Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.

  2004cited by this paper
• Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys.

  2004cited by this paper
• Melatonin: clinical relevance.

  2003cited by this paper
• Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep

  2003cited by this paper
• Targeted Disruption of the Mouse Mel1b Melatonin Receptor

  2003cited by this paper
• Melatonin in Children and Adolescents with Insomnia: A Retrospective Study

  2003cited by this paper
• Critical Role of Dorsomedial Hypothalamic Nucleus in a Wide Range of Behavioral Circadian Rhythms

  2003cited by this paper
• Melatonin, circadian rhythms, and sleep

  2003cited by this paper
• Melatonin potentiates 5‐HT1A receptor activation in rat hypothalamus and results in hypothermia

  2002cited by this paper
• Contrasting Effects of Ibotenate Lesions of the Paraventricular Nucleus and Subparaventricular Zone on Sleep–Wake Cycle and Temperature Regulation

  2001cited by this paper
• Melatonin treatment for age-related insomnia.

  2001cited by this paper
• Increased bioavailability of oral melatonin after fluvoxamine coadministration

  2000cited by this paper
• Melatonin for the treatment of handicapped children with severe sleep disorders.

  2000cited by this paper
• The use of melatonin for sleep.

  1998cited by this paper
• Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome.

  1998cited by this paper
• Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock.

  1997cited by this paper
• Melatonin receptors step into the light: cloning and classification of subtypes.

  1996cited by this paper
• Melatonin replacement therapy of elderly insomniacs.

  1995cited by this paper
• Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance.

  1994cited by this paper
• Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation

  1993cited by this paper
• Melatonin shifts human circadian rhythms according to a phase-response curve.

  1992cited by this paper

• Sleep Disorders and Male Infertility: Integrated Mechanisms and Precision Therapeutic Strategies.

  2026cites this paper
• Synthesis of 2,3-Dihydrobenzofuran Chalcogenides Under Visible Light: A Sustainable Approach

  2025cites this paper
• Association between fish consumption and sleep disorders among Chinese adults: a cross-sectional study

  2025cites this paper
• Progress in Synthetic Approaches and Pharmacological Applications of Melatonin and Its Derivatives: A Comprehensive Review.

  2025cites this paper
• The vascular influence of melatonin on endothelial response to angiotensin II in diabetic rat aorta

  2024cites this paper
• A Novel Sublingually Applied Melatonin Nanoemulsion Ensures Rapid Onset of Action

  2024cites this paper
• Significance of Melatonin in the Regulation of Circadian Rhythms and Disease Management

  2024cites this paper
• Activation of the Melatonin Receptor MT1 by the Natural Product Gastrodin to Promote Sleep

  2024cites this paper
• Myrica rubra Preharvest Treatment with Melatonin Improves Antioxidant and Phenylpropanoid Pathways During Postharvest Storage

  2024cites this paper
• Melatonin Treatment in Kidney Diseases

  2023cites this paper
• Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions

  2022cites this paper
• Evaluation of the Protective Effect of Ramelteon in Methotrexate Induced Nephrotoxicity

  2022cites this paper
• Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies

  2021influential citation
• Ultrasound Promoted Stereoselective Synthesis of 2,3-Dihydrobenzofuran Appended Chalcones at Ambient Temperature

  2020cites this paper
• Melatonin as an Anti-Cancer Molecule: A Retrospective Perspective

  2020cites this paper
• Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety.

  2020cites this paper
• Epigenetic regulation of melatonin receptors in neuropsychiatric disorders

  2018cites this paper
• Effects of hypnotics on prefrontal cortex activity during a verbal fluency task in healthy male subjects: A near‐infrared spectroscopy study

  2018cites this paper
• Biotechnological Potential of Rhodococcus Biodegradative Pathways.

  2018cites this paper
• Exploring Links between Mother and Infant through Human Milk Diurnal Melatonin Rhythm in Human Milk and Association of Maternal Diet and BMI with Infant Gut Bacteria

  2018cites this paper
• Melatonergic Sleep Promotion: Fundamental Chronobiological Issues Concerning Sleep Onset and Maintenance, Dose and Duration of Action

  2018cites this paper
• Dietary Sources and Bioactivities of Melatonin

  2017cites this paper
• Zolpidem's use for insomnia.

  2017cites this paper
• Considering Drug Metabolism and Molecular Complexity in Drug Design

  2017cites this paper
• Sleep, Melatonin, and the Menopausal Transition: What Are the Links?

  2016cites this paper
• A Review of Melatonin, Its Receptors and Drugs.

  2016cites this paper
• Melatonergic Treatment: Focus on Metabolism and Chronobiology

  2016cites this paper
• Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches.

  2016cites this paper
• Sleep Disorders in Shift Workers in the Emergency Department and Efficacy of Melatonin

  2016cites this paper
• Melatonin in Clinical Status of Patients with Fibromyalgia Syndrome

  2016cites this paper
• Melatonergic Treatment: Chronobiological Basis and translational Problems

  2016cites this paper
• Clinical Associations of Chronotypes in Adolescents and Young Adults with Mental Disorders

  2016cites this paper
• Pathophysiological and pharmacological modulation of melatonergic system

  2015cites this paper
• MT 3 Receptor Selective Ligands in the Treatment of Glaucoma : Achievements and Prospects

  2015cites this paper
• A Case of Unilateral Hypnic Headache: Rapid Response to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist

  2015influential citation
• The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers

  2014cites this paper
• The melatonin receptor agonist is effective for free-running type circadian rhythm sleep disorder: case report on two sighted patients.

  2014cites this paper
• Melatonin and Its Agonists in Sleep Disorders

  2014cites this paper
• Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.

  2014cites this paper
• Possible Role of Exogenous Melatonin and Melatonin-Receptor-Agonists in the Treatment of Menopause―Associated Sleep Disturbances

  2014cites this paper
• Current Clinical Practice of Insomnia

  2013cites this paper
• Actualidades en las aplicaciones clínicas de la melatonina en trastornos del sueño

  2013cites this paper
• MELATONIN DAN MELATONIN RECEPTOR AGONIST SEBAGAI PENANGANAN INSOMNIA PRIMER KRONIS

  2013cites this paper
• Etude du récepteur humain de la mélatonine MT1 par des approches in vitro : mise au point des conditions de production, de purification et de caractérisation fonctionnelle

  2013cites this paper
• Characterization and engineering of an o-xylene dioxygenase for biocatalytic applications.

  2013cites this paper
• Chapter 12 Circadian Rhythms in the Physiopathology of Depression: A New Opportunity of Therapeutic Approach

  2013cites this paper
• Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus—Consequences to Melatonin Dysfunction

  2013cites this paper
• Sleep medicine pharmacotherapeutics overview: today, tomorrow, and the future (Part 1: insomnia and circadian rhythm disorders).

  2012cites this paper
• Cardiovascular effects of melatonin receptor agonists

  2012cites this paper
• Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction

  2012influential citation
• Alzheimer's Disease: Focus on the Neuroprotective Role of Melatonin

  2012cites this paper
• Recent progress in the development of agonists and antagonists for melatonin receptors.

  2012cites this paper
• Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system.

  2012cites this paper
• Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

  2012cites this paper
• Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.

  2012cites this paper
• Melatonin and its analogs in insomnia and depression

  2012cites this paper
• Sleep medicine pharmacotherapeutics overview: today, tomorrow, and the future (part 2: hypersomnia, parasomnia, and movement disorders).

  2012cites this paper
• Ramelteon

  2012cites this paper
• Melatonin in Aging and Disease ―Multiple Consequences of Reduced Secretion, Options and Limits of Treatment

  2012cites this paper
• 3-Methoxylphenylpropyl amides as novel receptor subtype-selective melatoninergic ligands: characterization of physicochemical and pharmacokinetic properties

  2011cites this paper
• Noradrenergic System in Depression

  2011cites this paper
• Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

  2011influential citation
• Circadian Phase in Chronic Insomnia

  2011cites this paper
• Chronobiological Rhythms, Melatonergic System, and Depression

  2011cites this paper
• Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications

  2011cites this paper
• Tasimelteon for insomnia

  2011cites this paper
• Neurochemical and Neuropharmacological Aspects of Circadian Disruptions: An Introduction to Asynchronization

  2011cites this paper
• The Impact of Melatonin, Melatonin Analogues, Caffeine, and Bright Light on Sleep and Thermoregulatory Physiology

  2010cites this paper
• Investigational melatonin receptor agonists

  2010influential citation
• MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).

  2010cites this paper
• INSOMNIA IS A COMMON SYMPTOM OF CIRCADIAN SLEEP DISORDERS.1 CIRCADIAN SLEEP DISORDERS ARE A SPECIAL CLASS OF SLEEP DISORDERS THAT

  2010cites this paper
• Chronophysiology of Melatonin: Therapeutical Implications

  2010cites this paper
• Effects of the melatonin MT-1/MT-2 agonist ramelteon on daytime body temperature and sleep.

  2010cites this paper
• Sleep-inducing effect of beer: a melatonin- or alcohol-mediated effect?

  2010cites this paper
• Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.

  2010cites this paper
• Principles and Practice of Geriatric Sleep Medicine: Melatonin, aging, and Alzheimer's disease

  2009cites this paper
• Dosing time-dependent actions of psychostimulants.

  2009cites this paper
• Influência da Ingestão de Álcool na Produção de Melatonina Pineal e suas Conseqüências sobre a expressão dos receptores de melatonina e dos genes relógio no Sistema Nervoso Central

  2009cites this paper
• Pharmacotherapy of Insomnia: Focus on Zolpidem Extended Release

  2009cites this paper
• Pathophysiology of depression: role of sleep and the melatonergic system.

  2009cites this paper
• Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

  2009cites this paper
• Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action

  2009cites this paper
• Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.

  2009cites this paper
• Pharmacology of Ramelteon, a Selective MT1/MT2 Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders

  2009cites this paper
• New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

  2009cites this paper
• Melatonin: Signaling mechanisms of a pleiotropic agent

  2009cites this paper
• Melatonin: a hormone that modulates pain.

  2009cites this paper
• New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

  2009cites this paper
• The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives

  2009cites this paper
• 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.

  2009cites this paper
• ZOLIDEM AND SLEEP-DEPENDENT cORTIcAL PLASTIcITy The NonBenzodiazepine Hypnotic Zolpidem Impairs Sleep-Dependent Cortical Plasticity

  2008cites this paper
• Melatonin Beyond Its Classical Functions

  2008cites this paper
• Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.

  2008cites this paper
• Suprachiasmatic nucleus and melatonin

  2008cites this paper
• Ramelteon: a melatonin receptor agonist for the treatment of insomnia.

  2008cites this paper
• Agomelatina: un nuevo enfoque farmacológico en el tratamiento de la depresión con traducción clínica

  2008cites this paper
• Detection of Rh antibodies using two low ionic diluents: extension of the incubation time and the number of Rh antibodies detected.

  2008cites this paper
• Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.

  2008cites this paper
• The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity.

  2008cites this paper
• Melatonergic Drugs in Clinical Practice

  2008cites this paper